Coronary artery blood flow: physiologic and pathophysiologic regulation

L Feliciano1, R J Henning

  • 1Department of Medicine, University of South Florida College of Medicine, Tampa, Florida, USA.

Clinical Cardiology
|January 8, 2000
PubMed

Insights

Understanding coronary blood flow regulation is vital for treating myocardial ischemia in millions with coronary artery disease. This review details mechanisms and clinical issues impacting blood flow, emphasizing nitric oxide

Area of Science:

  • Cardiovascular Physiology
  • Pathophysiology

Background:

  • Acute myocardial ischemia affects millions with atherosclerotic coronary artery disease due to oxygen supply-demand imbalance.
  • Understanding coronary blood flow regulation is crucial for effective clinical treatment strategies.

Purpose of the Study:

  • To review the physiological and pathophysiological factors influencing coronary artery blood flow.
  • To highlight the role of nitric oxide in regulating coronary blood flow.
  • To discuss clinical conditions impairing coronary blood flow regulation.

Main Methods:

  • Review of endothelial, metabolic, myogenic, and neurohumoral mechanisms.
  • Discussion of interactions between regulatory mechanisms.
  • Analysis of clinical problems affecting nitric oxide production and coronary blood flow.

Main Results:

  • Coronary blood flow is regulated by multiple interacting mechanisms.
  • Nitric oxide plays a critical role in maintaining adequate coronary blood flow.
  • Clinical conditions like hyperlipidemia, atherosclerosis, spasm, and hypertension impair nitric oxide pathways and blood flow regulation.

Conclusions:

  • Impaired coronary blood flow regulation, often due to endothelial dysfunction and reduced nitric oxide, contributes to myocardial complications.
  • Clinicians must understand these mechanisms to manage patients at risk for heart disease.

Related Concept Videos

Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...